最新出版物
Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis.
Ophthalmology. 2018; 125(9): 1332-1343
Bonini, S; Lambiase, A; Rama, P; Sinigaglia, F; Allegretti, M; Chao, W; Mantelli, F; REPARO Study Group
扩展阅读
Phase I Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis.
Ophthalomology. 2018; 125(9): 1468-1471
Bonini, S; Lambiase, A; Rama, P; Filatori, I; Allegretti, M; Chao, W; Mantelli, F; REPARO Study Group
扩展阅读
Substance P Modulation of Human and Murine Corneal Neovascularization.
Invest Ophthalmol Vis Sci. 2018; 59(3): 1305-1312
Barbariga, M; Fonteyne, P; Ostadreza, M; Bignami, F; Rama, P; Ferrari, G
扩展阅读
Cultivated limbal epithelial transplantation.
Curr Opin Ophthalmol. 2017; 28(4): 387-389
Rama, P; Ferrari, G; Pellegrini, G
扩展阅读
Time-Dependent Nerve Growth Factor Signaling Changes in the Rat Retina During Optic Nerve Crush-Induced Degeneration of Retinal Ganglion Cells.
Int J Mol Sci. 2017; 18(1) : 98
Mesentier-Louro, LA; De Nicolò, S; Rosso, P; De Vitis, LA; Castoldi, V; Leocani, L; Mendez-Otero, R; Santiago, MF; Tirassa, P; Rama, P; Lambiase, A.
扩展阅读
Angiopoietin 2 expression in the cornea and its control of corneal neovascularisation.
Br J Ophthalmol; 2016; May 4. Pii: bjophthalmol-20145-307901
Ferrari, G; Giacomini, C; Bignami, F; Moi, D; Ranghetti, A; Doglioni, C; Naldini, L; Rama, P; Mazzieri, R;
扩展阅读
From discovery to approval of an advanced therapy medicinal product-containing stem cells, in the EU.
Regen Med. 2016; 11(4): 407-20
Pellegrini, G; Lambiase, A; Macaluso, C; Pocobelli, A; Deng, S; Cavallini, GM; Esteki, R; Rama, P
扩展阅读
Substance P and its Inhibition in Ocular Inflammation.
Curr Drug Targets. 2016; 17(11): 1265-74
Bignami, F; Rama, P; Ferrari, G
扩展阅读
Response to "Pachymetry-Guided Intrastromal Air Injection ("Pachy-Bubble") for Deep Anterior Lamellar Keratoplasty: Results of the First 110 Cases".
Cornea. 2015; 34(10): e32
Rama, P; Knutsson, KA; Paganoni, G.
扩展阅读
